Since 2005, Biodesix has developed and commercialized blood-based tests that advance the speed and standard of care in oncology. Our diagnostics help patients and their doctors make more informed decisions about treatment based on a patient's unique molecular profile. We're advancing precision medicine by helping oncologists provide the right patient with the right treatment at the right time. Our two commercialized tests, VeriStrat® & GeneStrat™, offer results in 72 hours. No tissue is required. Our blood-based tests offer more complete information about the patient’s cancer
Company Growth (employees)
Boulder, US
Size (employees)
120 (est)+2%
Biodesix was founded in 2005 and is headquartered in Boulder, US

Key People/Management at Biodesix

David Brunel

David Brunel

Jim Purvis

Jim Purvis

Vice President of Human Resources and Operational Effectiveness
Paul Beresford

Paul Beresford

Vice President of Business Development and Strategic Marketing

Biodesix Office Locations

Biodesix has offices in Boulder, Amargosa Valley and Spring
Boulder, US (HQ)
100 2970 Wilderness Pl
Show all (2)

Biodesix Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$98.2 m

Latest funding size

$22 m

Time since last funding

almost 2 years
Biodesix's latest funding round in February 2016 was reported to be $22 m. In total, Biodesix has raised $98.2 m

Biodesix's Web-traffic and Trends

Biodesix Online and Social Media Presence

Biodesix Company Life and Culture

You may also be interested in